<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11721">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02071706</url>
  </required_header>
  <id_info>
    <org_study_id>114-2013-GES-0010</org_study_id>
    <nct_id>NCT02071706</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of an Integrated PET/MRI System</brief_title>
  <acronym>PET/MR  ZURICH</acronym>
  <official_title>Clinical Evaluation of an Integrated PET/MRI System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigational PET/MRI scanner, including attenuation correction method, is capable of
      producing diagnostic quality images and appropriate device functionality per user feedback.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>PET/MRI images of diagnostic quality</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator indicates are of diagnostic quality Yes/No</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Subjects With Clinical Indication for PET/CT</condition>
  <arm_group>
    <arm_group_label>Single-Arm PET/MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single-group evaluation of PET/MRI for diagnostic quality of image</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PET/MRI system</intervention_name>
    <arm_group_label>Single-Arm PET/MRI</arm_group_label>
    <other_name>PET/MRI system inlcudes:</other_name>
    <other_name>3T MR750w Magnet</other_name>
    <other_name>MR750w XRMw Gradient</other_name>
    <other_name>PET/MRI Body Coil</other_name>
    <other_name>Photon Detection Ring and PET Detectors</other_name>
    <other_name>PET/MR Patient Table</other_name>
    <other_name>PET Electronics (mounted to magnet) and Cables</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have a clinical indication for a PET/CT exam

          -  Subject must be at least eighteen (18) years of age; and

          -  Female subjects with negative urine pregnancy test performed within 24 hours prior to
             the clinical PET/CT imaging; and

          -  Subject must be able to hear and understand instructions without assistive devices;
             and

          -  Subject must provide written informed consent; and

          -  Subject has the necessary mental capacity to understand instructions, and is able to
             comply with protocol requirements; and

          -  Subject is able to remain still for duration of imaging procedure (approximately 60
             minutes total for PET/MRI); and

          -  Subject must be able to participate in a PET/MR imaging session within 1 hour of
             concluding their PET/CT exam

        Exclusion Criteria:

          -  Subjects who have any axial diameter larger than 55 cm; or

          -  Subjects with a weight greater than 227 kgs; or

          -  Pregnancy; or

          -  Subjects with any implants or external medical hardware; or

          -  Subjects who have a contraindication to MRI per the attached (see
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roee Lazebnik, Medical Doctor</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UniversitätsSpital Zürich</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustav von Schulthess, Medical Doctor</last_name>
      <phone>+41 44 255 25 80</phone>
      <email>gustav.vonschulthess@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Gustav von Schulthess, Medical Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Veit-Haibach, Medical Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 25, 2014</lastchanged_date>
  <firstreceived_date>February 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
